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Abstract
Background: Patients with COPD need to cope with a disabling disease, which leads to health status impairment.
Aim: To investigate the long term change of health status in subjects with mild to moderate airflow obstruction
and to compare this to subjects without airflow obstruction, with and without a smoking history. Second, to
investigate the factors potentially associated to rapid health status decline in our total cohort.
Methods: Two hundred and one subjects were included. Generic [Short form 36 health survey (SF36) and EuroQol
- 5 dimensions (EQ-5D)] and disease specific [Clinical COPD questionnaire (CCQ) and COPD Assessment Test (CAT)]
health status questionnaires were regularly repeated over a six years period. Other functional outcomes comprised
measures of lung function, physical fitness, physical activity and emotional state.
Results: On average, health status decline did not differ between groups with the exception of the EQ-5D index,
which deteriorated faster in subjects with airflow obstruction compared to the never smoking control group [− 0.
018(0.008) versus 0.00006(0.003), p = 0.03]. Subjects presenting at least one exacerbation had faster rate of deterioration
measured with CAT [0.91(0.21) versus − 0.26(0.25), p < 0.01]. Characteristics of the fast declining group were older age,
worse lung function, physical fitness, physical activity and disease specific baseline health status. Subjects with airflow
obstruction had a 2.5 (95% CI 1.36–4.71) higher risk of presenting fast overall health status decline. Fast overall decline
was associated with the presence of acute exacerbation(s) (44% of the subjects with exacerbation(s) versus 17% of
subjects without exacerbation, p = 0.03). Changes in fat free mass, functional exercise capacity and in symptoms of
anxiety and depression correlated weakly to changes in health status measured with all questionnaires.
Conclusion: Subjects with mild airflow obstruction present a significant deterioration of health status, which is
generally not much faster compared to smoking and never smoking controls. Subjects with fast decline in overall
health status are older and more likely to have airflow obstruction, acute respiratory exacerbation(s), reduced physical
fitness, physical activity and impaired COPD specific health status at baseline.
Trial registration: NCT01314807 - retrospectively registered on March 2011.
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Background
Health is defined by the World Health Organization
(WHO) as “a state of complete physical, mental and social
well-being, and not merely the absence of disease or infirm-
ity” [1]. Health status is one of the recommended targets in
the management of Chronic Obstructive Pulmonary Dis-
ease (COPD). Patients suffering from COPD present per-
sistent airflow limitation, and systemic consequences, such
as muscle dysfunction, impaired exercise tolerance, symp-
toms of dyspnea and fatigue and impaired health status [2].
Despite its overwhelming impact, COPD is still widely
underdiagnosed [3–5]. Especially in its mild or early stage,
COPD often remains under the diagnostic radar [3]. Un-
diagnosed subjects already have a decreased health status
compared to healthy controls. When diagnosed, patients
present an even worse outcome [4]. Therefore, it is likely
that (the perception of) a deteriorated health status is a
trigger for patients to seek for medical attention. Indeed, it
has already been shown that patients with COPD are more
likely to be referred to a respiratory specialist if they experi-
ence poor health status [6].
The deterioration of health status over time has previ-
ously been described by large and robust studies [7–12].
These studies evaluated patients with moderate to severe
stages of COPD. While cross-sectional studies showed that
health status was impaired in subjects with mild or undiag-
nosed airflow obstruction [13, 14], longitudinal change of
health status in the early stages of COPD has not been
described yet. This information would help to understand
how the impaired health status of clinical patients with
COPD is developed over time.
The present study aimed to 1) investigate the change in
health status of subjects with mild to moderate airflow ob-
struction over six years as compared to two control groups
without airflow obstruction, with and without a significant
smoking history, 2) to compare the baseline and change of
health status between subjects with or without at least one
acute exacerbation, 3) to characterize the subjects who
have a faster deterioration in overall health status during
the follow up and, finally, 4) to investigate possible associa-
tions between decline in health status and in functional
outcomes in all participants.
We hypothesized that subjects with mild to moderate
airflow obstruction would present faster deterioration in
health status compared to the control groups, particularly
when experiencing acute exacerbation(s) during follow up.
Methods
Design and subjects
Information regarding the study design, subjects recruit-
ment and inclusion criteria has been described elsewhere
[15, 16]. Briefly, this study is part of the Rainbow study, a
six years prospective, case-control, observational study,
which aimed to investigate the prevalence, severity and
incidence of systemic consequences in subjects with newly
detected mild and moderate airflow obstruction. Three
groups were included: 1) subjects with mild to moderate
airflow obstruction (‘airflow obstruction’, reference group),
2) (ex-) smokers with a significant smoking history but
without airflow obstruction (‘smoking controls’), and 3)
never or ex-smokers with a marginal (< 10 packyears)
smoking history (‘never smoking controls’). The rainbow
study was approved by the ethics committee of the Uni-
versity Hospital Leuven (B3220096387) and subjects were
included after signing a written informed consent term.
The study was retrospectively registered in the Clinical-
Trials.gov (NCT01314807) on March 2011.
Measurements
Health status
The main outcome of this analysis was health status,
assessed through self-administered patient reported out-
comes (PROs). Generic [Short form 36 health survey
(SF36) and Generic EuroQol - 5 dimensions (EQ-5D)], as
well as disease specific [Clinical COPD questionnaire
(CCQ) and COPD Assessment Test (CAT)] PROs were
collected. The smoking groups with and without airflow
obstruction responded to the SF36 and the EQ-5D at
baseline, one, two, three and six years, while the CCQ was
completed at every year until the end of the six years fol-
low up. The never smoking control group was only evalu-
ated at baseline, three and six years and in all visits all the
PROs were collected. The CAT was introduced in the
study 16months after its start.
The SF36 is a generic instrument widely used. It has
eight domains that can be summarized in two summary
scores: Physical component summary (PCS) and Mental
component summary (MCS) ranging from 0 (worse) to
100 (best) [17]. The EQ-5D questionnaire is a generic
instrument containing two sections: the utility index
(index) and the visual analog scale (VAS). The index is
calculated from five items (mobility, self-care, usual ac-
tivities, pain/discomfort and anxiety/depression) ran-
ging from 1 to 3. For the Dutch speaking Belgian
population, the final score ranges from − 0.158 to 1,
with higher scores indicating better health status and
death being scored as zero [18]. The VAS ranges from 0
(worst) to 100 (best), in which subjects indicate how
they rate their general health status. The CCQ is a
disease-specific questionnaire consisting of three
domains (symptoms, functional and mental) and a total
score, which ranges from zero to six and higher scores
indicate worse health related quality of life [19]. The
CAT is a disease-specific instrument evaluating the
impact of the disease on the patient’s well-being and
daily life. The total score ranges from zero (best) to 40
(worst) [20].
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Other outcomes
At inclusion and at every follow up visit, a comprehensive
interview was performed to assess the clinical history and
smoking status. The use of long acting beta agonists, long
acting anticholinergics or inhaled corticosteroids was con-
sidered maintenance respiratory pharmacotherapy. Acute
exacerbations were defined as a variation on respiratory
symptoms which required a change in medication or
hospitalization in the group with airway obstruction [2].
Functional outcomes were lung function, physical fitness,
physical activity (PA) and emotional state:
Lung function was measured according to European
Respiratory Society recommendations [21, 22], retrieving
values of forced expiratory volume in one second
(FEV1), functional residual capacity (FRC) and diffusion
capacity for carbon monoxide (TL,CO). Values were
compared to those predicted by Quanjer et al. [23] and
were used as natural units for decline.
The following physical fitness outcomes were assessed: 1)
body weight and height, resulting in body mass index
(BMI); 2) fat free mass (FFM), assessed by dual energy
X-ray absorptiometry (DXA) scan (QDR 4500A, Discovey
scanners, Hologic, Inc., Bedford, MA, USA) and expressed
as percentage of body weight and as FFM index (FFM/
height*height); 3) handgrip force, measured by the Jamar
hydraulic hand dynamometer (model J00105, Sammons
Preston Inc., Bolingbrook, Illinois), taking the highest of
three reproducible isometric contractions. Subjects were
seated with arms unsupported and elbow flexed at 90°
along de body. Results were compared to the normative
values proposed by Mathiowetz et al. [24]; 4) Quadriceps
force, via maximal voluntary isometric contraction, with
the computerized dynamometer (Biodex system 4 pro –
Enraf Nonius; Delft, the Nederlands) [25]. Reference values
were calculated as previously described [26]; 5) Functional
exercise capacity, as the distance during the six minutes
walking test (6MWD) [27]; 6) Maximal exercise capacity,
by a maximal incremental cycling test [16], taking peak
oxygen uptake (VO2peak) and the oxygen uptake efficiency
slope (OUES) as the main outcomes. Reference values of
VO2peak were those reported by Jones et al. [28].
Physical activity (PA) was assessed by an accelerometer
(Sensewear Pro 2 Armband Bodymedia, Pittsburgh, PA)
worn on the upper right arm during waking hours for
seven consecutive days. Valid PA measures were those
which contained at least four days with data from at
least eight hours per day, between 07:00 AM and 20:00
PM [29]. The number of steps per day and the total time
spent in moderate to vigorous PA (above 3 METS -
MVPA) were retrieved as variables of interest.
Finally, symptoms of anxiety and depression were
assessed by the Hospital Anxiety and Depression scale
(HADS) to have information on the emotional status of
the subjects [30]. Sum scores for each domain range from
zero (best) to 21 (worse). The score threshold of 8 points
is suggested as possible case of depression or anxiety [31].
Statistical analysis
Data handling and statistical analysis were performed
with SAS 9.4 (SAS Institute Inc., Cary, North Carolina,
USA). Comparison of continuous data from baseline
characteristics were performed by ANOVA or the
non-parametric equivalent (Kruskal-Wallis). Frequency
of gender, continuous smoking and group distribution,
as categorical data, was compared with the chi-square
test. Post hoc tests were performed considering the Bon-
ferroni correction for multiple comparisons.
First, to investigate differences in the yearly change in
health status among groups, a mixed model was built
(PROC mixed) for each of the main outcomes of interest
(i.e. SF-36, EQ-5D, CCQ and CAT). Group (class vari-
able with airflow obstruction group as reference), time
(continuous variable) and group x time interaction effect
(main interest) were inserted in the model. The intercept
(initial potency) and slopes (degradation rate), were indi-
cated as random effects. For CAT, we only compared the
airflow obstruction group to the smoking control group
because the follow up time in the never smoking group
was only 2.48 years (compared to the average of 3.95 and
4.1 years follow up from smoking control and airflow ob-
struction groups). Next, we stratified the analysis for
having at least one acute exacerbation (≥1 vs 0 events as
class variable) during follow-up among those subjects
with airflow obstruction, retrieving the interaction effect.
Age was included as covariate in the mixed models to
verify any potential interference in the main results.
Second, the individual rate of yearly change in health
status was calculated by a simple regression analysis
(PROC autoreg). This estimate (slope of the regression)
was obtained when at least two measurements during
follow up were available. These slopes were used as a
sensitivity analysis confirming the mixed model results.
Furthermore, the following exploratory analyses were
performed, based on the regression slopes:
(I) Characterization of subjects presenting fast decline
in overall health status. This was defined based on
an arbitrary sum score based on the rate of
deterioration (slopes) quartiles of SF36 PCS, SF36
MCS, EQ-5D VAS and CCQ. These questionnaires
cover the aspects of physical, mental, general and
disease specific health status. EQ-5D index and
CAT were not included because their aspects were
already covered by the previous instruments and
because the scores calculation of EQ-5D index is
country dependent and the implementation of CAT
was not done at the start of the study.
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For each one of the selected instruments, subjects
scored 0 (quartile of the slowest decline) to 3 (quartile of
the fastest decline). The quartile scores in each of those 4
instruments were summed for each subject. Those with a
sum score higher than 9 were classified as presenting fast
decline in overall health status. This cut off was chosen
because it is the threshold which covers all statistically sig-
nificant average declines in those four instruments and
due to the break of the linearity of the frequency distribu-
tion seen at the inspection of the histogram.
In case of missing values in at least one of the instru-
ments, the sum score was also considered missing. This
was overruled in case the category was already stablished
and would not change, independently of any potential
result of those missing results (2 out of 20 cases). For
comparisons (sum scores > 9 versus <=9), the independ-
ent T-test or the Mann-Whitney test was applied.
The relative risk of presenting fast decline if being in the
airflow obstruction group was investigated by the prob-
ability of presenting fast decline if being in the airflow ob-
struction group divided by the probability of presenting
fast decline if being in any of the control groups.
(II) Correlation of changes in health status with
changes in functional outcomes (i.e. lung function,
physical fitness, physical activity and emotional
state) was investigated using the Spearman
correlation coefficient.
For visual representation of the deterioration in the
outcomes of interest, the average and standard error es-
timated for each visit by the mixed models were plotted
in graphs using GraphPad Prism version 8 (GraphPad
Software Inc., San Diego, California, USA).
Results
Baseline characteristics
From the 201 subjects initially included in the Rainbow
cohort, 12 deceased and 32 dropped out of the study
along the follow up, resulting in 157 subjects who com-
pleted the six years follow up. The time of drop out is
depicted at the CONSORT like flow chart of inclusions
and follow up (Fig. 1). Drop-out rate was smaller in the
never smoking control group than in the smoking control
and airflow obstruction groups (6% versus 30 and 31%, p
< 0.001). Those who dropped out had higher smoking
history and presented worse lung function, functional
exercise capacity, symptoms of anxiety and health status
(Additional file 1: Table S1). Cause of deceases was mainly
cancer (lung – 2 cases, mouth, esophagus, brain, blood
and bile duct). Other causes were complications after lung
volume surgery, heart failure, neurologic condition and
suicide. We were not able to retrieve the information for
one occurrence.
The characteristics of the subjects included in the study
can be found in Table 1. Subjects in the smoking control
group were somewhat younger than those with airflow ob-
struction (p = 0.03). Five subjects from the never smoking
control group had an irrelevant smoking history (ranging
between one to seven packyears, with smoking cessation
five to 27 years before entering the study). The frequency
distribution of subjects actively smoking during the study
period did not differ between the groups of smokers with
or without airflow obstruction. Sixty five percent of the
airflow obstruction group was composed by subjects with
mild obstruction (FEV1 ≥ 80% predicted). The remaining
35% was composed by subjects with moderate airflow
obstruction (50 ≤ FEV1 < 80% predicted).
As expected, all lung function tests were worse in the
group with mild to moderate airflow obstruction compared
to both control groups. Measures of BMI and FFM as per-
centage of body weight were comparable among groups.
Handgrip force, quadriceps force, functional and maximal
exercise capacity and physical activity were to some extend
decreased in subjects with airflow obstruction when com-
pared to the control group(s). Emotional state was slightly
worse in subjects with airflow obstruction as they scored
more on depressive symptoms than the never smoking
control group. Only 12, 7, 1.5% (p = 0.07) of subjects had a
possible diagnosis of depression in the airflow obstruction,
smoking and never smoking control groups, respectively.
All the patient reported outcomes (PROs) used to measure
health status indicated impairment in the airflow obstruc-
tion group compared to the never smoking control
(Table 1).
Change in health status over time
Across the entire cohort, health status measured by
all PROs, with exception of CAT, significantly de-
creased over time (Table 2). The deterioration in
health status measured by EQ-5D index was faster in
the group with airflow obstruction than in the never
smoking control group (interaction effect p = 0.03)
(Table 2). Numerically, SF36 PCS, EQ-5D VAS, CCQ
and CAT scores had a faster decline in the airflow
obstruction group but this was not statistically signifi-
cant compared to the controls. The introduction of
age as a covariate in the mixed models did not
change the overall data (Additional file 2: Table S2).
The results obtained with the regression analysis con-
firmed the findings from the mixed models (Add-
itional file 3: Table S3). A visual representation of the
changes in health status measured with the different
instruments is depicted in Fig. 2.
Acute exacerbations
The comparison of baseline and yearly change of
health status between subjects with or without at
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least one acute exacerbation during the follow up can
be found in Table 3. From the 61 subjects with air-
flow obstruction, 25 subjects experienced at least one
exacerbation (36 events in total). The baseline health
status from those who experienced exacerbation(s)
during the follow up did not differ significantly from
those without events. The disease specific instruments
(CCQ and CAT) captured a numerically worse health
status at baseline in the group with at least one
exacerbation. The deterioration of health status mea-
sured by the CAT was faster in the group of subjects
with exacerbation(s). SF36 PCS and SF36 MCS
declined numerically faster in subjects with events
compared to those free of events, but this difference
did not reach statistically significance.
Exploratory findings
Fast decline in health status
One hundred eighty three subjects could be classified
regarding the decline in overall health status. Table 4 dis-
plays the rate of decline in functional outcomes in the
groups with fast and slower decline in health status. Com-
pared to the slow decline, the fast decline group had an
accelerated rate of decline in FFM as percentage of body
weight, functional exercise capacity and symptoms of anx-
iety and depression. The Additional file 4: Table S4 pre-
sents the baseline characteristics of both groups. Subjects
with fast decline in overall health status were older, had
worse lung function, lower functional exercise capacity
(6MWD), oxygen uptake efficiency (OUES) and phys-
ical activity (PA) at baseline compared to the group
Fig. 1 CONSORT type flow chart of inclusions and follow up. Drop outs are indicated immediately after the last attended visit. In case of
decease, this is also indicated after the last attended visit by the subject, even if the decease occurred at a later stage. The number of
deceases between two visits are included in the number of drop outs and are specified within brackets
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with a slower decline. The emotional state did not differ
between groups. Health status, measured by the CCQ was
impaired at baseline in subjects with fast decline. Thirty
percent of the subjects with airflow obstruction presented
a fast decline in health status, while this percentage was
lower in the smoking and never smoking control groups,
with respectively 13 and 10% of subjects in the fast decline
group. Therefore, the relative risk of being in the fast de-
cline group is 2.5 (95% CI 1.36–4.71) fold increased in the
airflow obstruction group compared to that in the control
groups combined. The occurrence of at least one acute ex-
acerbation in the airflow obstruction group predisposed to
fast decline in overall health status. Forty four percent of
people experiencing exacerbation(s) were classified in the
fast decline group compared to 17% of those without
events (p = 0.03).
Correlation
The results of the correlation between the yearly rate of
decline in health status and in functional outcomes are








Age (years) 64 ± 7 60 ± 7 c 61 ± 7 0.03
Gender [n (%men)] 45 (74) 45 (61) 36 (55) 0.07
Smoking history (packyears) 48 ± 21 35 ± 20 0.38 ± 1.46b < 0.0001
Active Smoking during study [n (%)] 30 (50) 44 (60) 0 (0) cd < 0.0001
Lung function
FEV1 (% predicted) 85 ± 16 104 ± 14 116 ± 19
b < 0.0001
FRC (% predicted) 129 ± 26de 108 ± 17 112 ± 19 < 0.0001
TL,CO (% predicted) 79 ± 17 87 ± 14 96 ± 16
b < 0.0001
Physical fitness
BMI (kg/m2) 27 ± 4 27 ± 4 25 ± 3 0.08
FFM (% body weight) 73 ± 7 73 ± 7 73 ± 7 0.92
Handgrip force (% predicted) 99 ± 17 100 ± 18 108 ± 20cd 0.01
Quadriceps force (% predicted) 98 ± 22 95 ± 17 111 ± 26cd < 0.0001
6MWD (meter) 587 ± 84 608 ± 69 673 ± 75cd < 0.0001
VO2peak (% predicted) 111 ± 28 122 ± 32 129 ± 33
c < 0.01
OUES (slope) 2623 ± 628 2606 ± 588 2704 ± 780 0.60
Physical activity
Steps per day 7814 ± 3786de 9532 ± 3759 10,387 ± 3326 < 0.001
MVPA (minutes) 82 ± 66de 114 ± 67 115 ± 54 < 0.01
Emotional state
HADS anxiety (score) 4 [3–7] 4 [1–6] 3 [2–6] 0.16
HADS depression (score) 2 [1–4] 2 [1–4] 1 [0–2]cd < 0.0001
Health status measures
SF36 PCS (sum score) 76.2 [64.6–81.3] 81.2 [71.5–85.4] 85.8 [78.8–90]b < 0.0001
SF36 MCS (sum score) 79.5 [72.8–85] 82.2 [77.8–87] 86 [82–90.6] cd < 0.0001
EQ-5D index (score) 0.76 [0.74–1] 0.76 [0.76–1] 1 [0.76–1] 0.05
EQ-5D VAS (score) 75 [70–85] 80 [75–85] 80 [80–90] cd < 0.01
CCQ (total score) 0.7 [0.4–1.5] 0.4 [0.2–0.7] 0.2 [0.1–0.4]b < 0.0001
CAT (score)a 10 [5–14] 8 [4.5–11] 5 [3–8] cd < 0.0001
Data are expressed as mean ± SD, number (%) or median [interquartile range]. FEV1 forced expiratory volume in one second, FRC Functional residual capacity,
TL,CO diffusion capacity for carbon monoxide, BMI body mass index, FFM fat free mass, 6MWD six minutes walking distance, VO2peak peak oxygen uptake, OUES
oxygen uptake efficiency slope, MVPA time spent in moderate to vigorous physical activity, HADS Hospital Anxiety and Depression Scale, SF36 Short form 36
health survey, PCS physical component summary, MCS mental component summary, EQ-5D Generic EuroQol 5 dimensions, VAS visual analog scale, CCQ Clinical
COPD Questionnaire, CAT COPD assessment test (a= data from the third year visit as data collection was only initiated 18 months after the start of the study).
Missing values: FRC n = 4, TL,CO n = 3, FFM n = 15, handgrip n = 5, quadriceps n = 8, 6MWD n = 5, VO2peak and OUES n = 10, physical activity n = 15, HADS n = 6,
SF36 n = 5, EQ-5D VAS n = 6, EQ-5D index n = 6, CCQ n = 13, CAT n = 41. b = statistical difference among all groups; c = statistically different from airflow
obstruction; d = statistically different from smoking control; e = statistically different from never smoking control
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shown in the Additional file 5: Table S5. The deterioration
in functional exercise capacity, in fat free mass as percent-
age of body weight and in symptoms of anxiety and
depression was consistently correlated to the decline in
health status measured by SF36 PCS, SF36 MCS, EQ-5D
VAS and CCQ. The strength of this correlation was, at
best, moderate. The decline in EQ-5D VAS correlated
weakly with the decline in FEV1 and in handgrip force.
Discussion
Summary of findings
It has been previously reported that patients with mild
to moderate airflow obstruction present health status
impairment [13, 14]. To the best of our knowledge, this
is the first study with a prospective and controlled de-
sign to show the six years longitudinal change of health
status in early stages of airflow obstruction compared to
smoking and non-smoking control groups. We showed
that the decline in health status measured by the EQ-5D
index is faster in subjects with mild to moderate airflow
obstruction compared to relevant control populations
(Table 2 and Fig. 2). Other instruments (SF36 PCS,
EQ-5D VAS, CCQ and CAT) also presented the same
pattern of somewhat more deterioration in the airflow
obstruction group, but without statistically significance
(Table 2 and Fig. 2). Second, we showed that subjects
with airflow obstruction experiencing at least one acute
exacerbation during follow up had a trend for worse
COPD specific health status at baseline and had a faster
deterioration measured by the CAT score (Table 3).
Our exploratory analyses showed that our cohort
with mild to moderate airflow obstruction is at in-
creased risk of having a fast deterioration of overall
health status, based on an arbitrary sum score includ-
ing all instruments (Additional file 4: Table S4 and
main text of results). Those subjects with faster de-
cline in overall health status presented a faster decline
in functional outcomes such as fat free mass, func-
tional exercise capacity and emotional state (Table 4).
The occurrence of acute exacerbation(s) in the airflow
obstruction group was also associated to faster
decline in overall health status (main text of results).
Finally, in all participants, the decline in health status
was consistently but weakly correlated to changes in
fat free mass, functional exercise capacity and emo-
tional state (Additional file 5: Table S5).
Impaired health status is well documented in
patients with moderate to very severe COPD [2].
Therefore, we hypothesized that, by following up sub-
jects with newly diagnosed and early stages of airflow
Table 2 Estimated yearly rate of change in health status
All Group




SF36 PCS (sum score) −0.560 (0.162) Airflow obstruction (ref) −0.983(0.355)* –
(generic) p < 0.001 Smoking control −0.444(0.248) 0.18
Never smoking control −0.434(0.253) 0.18
SF36 MCS (sum score) −0.440 (0.160) Airflow obstruction (ref) −0.481(0.362) –
(generic) p < 0.01 Smoking control −0.486(0.288) 0.93
Never smoking control −0.483(0.182)* 0.92
EQ-5D index (score) −0.010 (0.003) Airflow obstruction (ref) −0.018(0.008)* –
(generic) p < 0.01 Smoking control −0.013(0.006)* 0.59
Never smoking control 0.00006(0.003) 0.03
EQ-5D VAS (score) −0.325 (0.129) Airflow obstruction (ref) −0.597(0.285)* –
(generic) p = 0.01 Smoking control −0.461(0.247) 0.64
Never smoking control −0.095(0.157) 0.13
CCQ (total score) 0.031 (0.007) Airflow obstruction (ref) 0.054(0.019)* –
(disease specific) p < 0.0001 Smoking control 0.021(0.009)* 0.05
Never smoking control 0.023(0.008)* 0.08
CAT (score) 0.073 (0.109) Airflow obstruction (ref) 0.285(0.187) –
(disease specific) p = 0.50 Smoking control −0.103(0.124) 0.09
Data are expressed as mean (standard error). SF36 = Short form 36 health survey, PCS = physical component summary, MCS =mental component summary, EQ-5D
= Generic EuroQol 5 dimensions, VAS = visual analog scale, CCQ = Clinical COPD Questionnaire, CAT = COPD assessment test. * indicates a statistical significant
change (p < 0.05)
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obstruction, we could detected a faster rate of decline in
health status compared to control groups. In line with this
hypothesis, most instruments used to measure health status
(both generic and disease specific) in our study showed a
slightly faster deterioration of health status in the airflow ob-
struction group. Only EQ-5D index presented a statistically
significant faster decline in the airflow obstruction compared
to the never smoking control group. The fact that this in-
strument could detect a significant difference is likely due to
its ability to provide a value to decease (score 0) [18]. Indeed,
mortality was slightly higher in the airflow obstruction group
and was mainly caused by smoking related conditions.
Fig. 2 Visual representation of the changes in health status obtained with the mixed model. Data as average and standard error. Panel a) Short
form 36 health survey physical component summary (SF36 PCS); b) Short form 36 health survey mental component summary (SF36 MCS); c)
Generic EuroQol 5 dimensions utility index (EQ-5D index); d) Generic EuroQol 5 dimensions visual analog scale (EQ-5D VAS); e) Clinical COPD
Questionnaire (CCQ); f) COPD assessment test (CAT). The airflow obstruction group (AO) is represented by circles and solid black line, the
smoking control group (SC) by squares and solid dark grey line and the never smoking control group (NSC) by triangles and dashed light grey
line. AO n=, SC n= and NSC n = refer to the number of valid of measurements in the three groups, in each time-point, for each instrument
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Health status deterioration in the present cohort
compared to others
Previous literature reported on the disease specific St
George’s Respiratory Questionnaire (SGRQ) to assess the
deterioration in health status of patients with more ad-
vanced COPD. The SGRQ was not included in the present
study. The calculation of the time to reach a clinically
meaningful deterioration in health status enables the com-
parison of results among studies using different instru-
ments. Our cohort of mild to moderate airflow obstruction
presented a slower rate of deterioration than the previously
reported on more severe COPD. In the Uplift [9] and
Eclipse [12] studies, a clinically meaningful deterioration
occurs after four years (0.99 and 1.3 points per year in the
SGRQ score, respectively). In our cohort it occurs after
seven years in the disease specific questionnaires (CCQ and
CAT), which was substantially longer.
Exacerbations have a significant effect on health status
deterioration in patients with more severe COPD [7, 32,
33]. The impact of the acute exacerbations in milder
disease was not studied so far. We found that subjects
experiencing at least one exacerbation during the follow
up had a numerically worse baseline health status mea-
sured by the COPD specific instruments (CCQ and CAT).
The average scores, however, were still lower than those
reported in typical patients with COPD [34, 35]. Although
the between group differences in our study were not
statistically different, their magnitude exceeded the min-
imal clinically important difference previously proposed
for these instruments [36, 37]. Miravitlles et al. [33] also
found impaired baseline health status in patients with
moderate to very severe COPD experiencing frequent ex-
acerbations (i.e. ≥2 per year). In our study, all instruments
presented a numerically higher rate of decline in the
group which experienced at least one exacerbation during
the follow-up. Only CAT showed a statistically faster de-
terioration in health status compared to the group without
events. The lack of consistent statistically significant find-
ings in this comparison is probably due to the relatively
low sample size, the low number of exacerbations and the
stratification based on at least one acute exacerbation
during the entire follow up.
Exploratory findings
Airflow obstruction and infrequent exacerbations are
related to fast deterioration in overall health status
We isolated a subgroup of subjects (17% of the whole
sample) with consistent fast decline in health status across
the different instruments aiming to minimize the bias of
using a single instrument. Subjects with airflow obstruc-
tion had a 2.5 fold increased risk to be in this group of fast
decline in overall health status. While the general differ-
ence in decline of health status between subjects with air-
flow obstruction and controls seems to be modest, this
increased risk deserves the attention of clinicians who see
these patients in primary care. The occurrence of exacer-
bation(s) in the group of subjects with airflow obstruction
was also related to fast deterioration in overall health
Table 3 Comparison of baseline and yearly change of health status between subjects with or without at least one acute
exacerbation during the follow up, among those with airflow obstruction
Exacerbation(s) during follow up No exacerbation during follow up p
(n = 25) (n = 36)
Baseline
SF36 PCS (sum score) 76.4 [65.1–82] 76 [64.6–81.3] 0.92
SF36 MCS (sum score) 79.5 [72.5–84.3] 80.1 [74.0–85.8] 0.79
EQ-5D index (score) 0.76 [0.74–1] 0.77 [0.76–1.00] 0.70
EQ-5D VAS (score) 75 [70–80] 80 [70–85] 0.48
CCQ (total score) 1.2 [0.3–1.5] 0.70 [0.40–1.00] 0.22
CAT (score)a 10.5 [6–17.5] 8 [5–13] 0.11
Yearly change
SF36 PCS (sum score) −1.51 (0.47) −0.50 (0.53) 0.16
SF36 MCS (sum score) −1.22 (0.54) 0.03 (0.45) 0.16
EQ-5D index (score) −0.022 (0.010) −0.015 (0.012) 0.66
EQ-5D VAS (score) −0.82 (0.47) − 0.40 (0.35) 0.48
CCQ (total score) 0.068 (0.025) 0.042 (0.028) 0.63
CAT (score) 0.91 (0.21) −0.26 (0.25) < 0.01
Data are expressed as median [interquartile range] or average (SE). Baseline data were compared with a Mann–Whitney test, yearly change with a mixed model.
SF36 = Short form 36 health survey, PCS = physical component summary, MCS =mental component summary, EQ-5D = Generic EuroQol 5 dimensions, VAS = visual
analog scale, CCQ = Clinical COPD Questionnaire, CAT = COPD assessment test (a= data from the third year visit). Missing values: Had acute exacerbation(s) – EQ-
5D index and CAT n = 1, CCQ n = 3, in both baseline and yearly change. Did not have acute exacerbation – Baseline: SF36 n = 1, EQ-5D index and CCQ n = 3, EQ-
5D VAS n = 2, CAT n = 13. Yearly change: SF36 and EQ-5D index n = 7, EQ-5D VAS n = 8, CCQ n = 9, CAT n = 12
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status. These findings reinforce the need to closely follow
up these subjects in order to prevent exacerbations and,
consecutively, the accelerated deterioration in health
status.
Baseline characteristics of subjects with fast deterioration in
overall health status
Our findings confirmed data from the TORCH study [7]
by showing that a rapid loss of health status was related to
older age. Subjects singled out as having fast decline in
overall health status in our analysis presented worse lung
function, physical fitness outcomes and had lower PA than
those presenting slower decline. This could potentially be
associated with frailty developed at older age. The Eclipse
study also found a functional limitation measured with
the timed up and go test (TUG) to be associated with a
clinical important deterioration in health status of patients
with COPD [38]. These results corroborate our findings,
although our cohort with airflow obstruction presented
more preserved lung function and physical fitness
outcomes.
Additionally, in the Eclipse study [38], baseline symptoms
of depression and worsening in dyspnea also were predic-
tors of deterioration in health status. This was not con-
firmed in the present cohort. However, scores for depressive
symptoms were generally low at baseline. The disease spe-
cific CCQ, which comprises symptoms in its assessment,
was worse at baseline in our subjects with fast decline.
Although subjects in the fast decline in overall health sta-
tus did not present faster deterioration in PA, they did
present lower levels of PA at baseline compared to the
slower overall decline group. Physical inactivity is known to
be related to the development of several chronic diseases
and to poor prognosis [39]. Therefore, it is not surprising
that subjects presenting fast decline in health status were
less active than those with slower decline. A large
Table 4 Comparison of decline in functional outcomes and in health status between groups with fast and slower decline in health
status
Fast decline Slower decline p
(n = 31) (n = 152)
Lung function
Δ FEV1 (liter) −0.04 [− 0.05 – − 0.02] -0.02 [− 0.05–0.00] 0.09
Δ FRC (liter) 0.027 [− 0.047–0.086] 0.009 [−0.036–0.064] 0.74
Δ TL,CO (ml/min/kPa) − 0.047 [− 0.220 – − 0.010] −0.067 [− 0.173–0.010] 0.74
Physical fitness
Δ BMI (kg/m2) 0.06 [− 0.10–0.26] 0.09 [− 0.06–0.24] 0.88
Δ FFM (% body weight) −0.49 [− 0.77 – − 0.17] −0.22 [− 0.45–0.03] 0.02
Δ Handgrip (kg) −0.49 [− 1.29 – − 0.11] −0.33 [− 0.83–0.21] 0.08
Δ Quadriceps force (Nm) −3.83 [− 6.07 – − 1.92] −3.20 [− 6.56 – − 0.57] 0.61
Δ 6MWD (meter) −7.27 [− 13.02 – − 1.00] − 2.12 [− 6.94–3.26] < 0.01
Δ VO2peak (l/min) −0.06 [− 0.10 – − 0.02] −0.075 [− 0.13 – − 0.03] 0.50
Δ OUES (slope) − 45 [− 103–7] − 57 [− 116 – − 2] 0.58
Physical activity
Δ Steps/day − 222 [− 591 – − 66] − 268 [− 525–92] 0.72
Δ MVPA (minutes) −2.72 [− 6.50–3.92] −1.38 [− 7.86–4.21] 0.89
Emotional state
Δ HADS anxiety (score) 0.32 [−0.03–0.56] −0.08 [− 0.33–0.13] < 0.0001
Δ HADS depression (score) 0.28 [0.00–0.81] 0.00 [− 0.17–0.16] < 0.001
Health status
Δ SF36 PCS (sum score) −3.02 [− 5.13 – − 2.13] 0.02 [− 0.89–0.59] < 0.0001
Δ SF36 MCS (sum score) −2.38 [− 4.88 – − 0.95] 0.14 [− 0.47–0.76] < 0.0001
Δ EQ-5D VAS (score) −2.49 [− 4.57 – − 1.18] 0 [− 0.73–0.84] < 0.0001
Δ CCQ (total score) 0.100 [0.050–0.177] 0.007 [− 0.020–0.039] < 0.0001
Data are expressed as median [interquartile range]. FEV1 = forced expiratory volume in one second, FRC = Functional residual capacity, TLCO = diffusion capacity for
carbon monoxide, BMI = body mass index, FFM = fat free mass, 6MWD = six minutes walking distance, MVPA = time spent in moderate to vigorous physical
activity, HADS = Hospital Anxiety and Depression Scale. Missing values: Fast decline – FEV1, FRC, TL,CO, handgrip force, 6MWD and HADS n = 1, FFM index n = 8,
quadriceps force n = 2, VO2peak and OUES n = 3. Slower decline – FFM index n = 18, 6MWD, EQ-5D, CCQ n = 1, VO2peak, OUES and CCQ n = 7, physical
activity n = 11
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epidemiologic study in China also showed that PA is associ-
ated with better psychological well-being, lower likelihood
of having chronic diseases and disabilities and a slower cog-
nitive impairment over time [40].
The group with fast deterioration in overall health sta-
tus was not exclusively composed by subjects with air-
flow obstruction. The other characteristics above
mentioned (higher age, worse functional exercise cap-
acity and oxygen uptake efficiency and less physical ac-
tivity) could be risk factors for cardiovascular and
metabolic comorbidities. These risk factors might have
contributed to the faster deterioration in health status of
control subjects [41, 42].
Surprisingly, the quadriceps force, as percentage of the
predicted, was higher in the fast decline group. This is
counter intuitive, but probably reflects the average older
age and lower body weight, both impacting on the pre-
dicted quadriceps force in this group. The values of
quadriceps force, corrected by body weight, tended to be
lower in the group with fast decline, although this differ-
ence was not statistically significant.
Deterioration in functional outcomes of subjects with fast
deterioration in overall health status
Deterioration in FFM (% body weight), functional exercise
capacity and symptoms of anxiety and depression was fas-
ter in the fast health status group compared to the slower
decline. While the criteria chosen to classify fast deterior-
ation might be arbitrary, the results from the correlation
analysis between changes in health status and in func-
tional outcomes in all subjects were reassuring, although
correlations were generally weak. Changes in symptoms of
anxiety and depression, also measured by a patient
reported outcome, consistently correlated with changes in
health status. Previous studies also indicated a weak
correlation between function and health status [8, 10, 43],
underscoring the importance of measuring patients’ re-
ported health status. Interestingly, the change in fat free
mass as percentage of body weight and functional exercise
capacity were also consistently (but moderately) related to
decline in health status. This provides further validity to
this outcome as an integrated measure of overall health in
elderly with or without airflow obstruction.
Strengths and limitations
Previous studies have mainly focused on moderate to very
severe stages of COPD in either observational [10, 11, 38]
or interventional [7–9] designs, mostly without including
a healthy aging control group. In the present study, the
included subjects were diagnosed with mild to moderate
airflow obstruction as a result of a screening spirometry in
a population based study from our center rather than
following a clinical diagnosis. This allowed the investiga-
tion of the longitudinal changes from an early onset of the
disease. Furthermore, two relevant control groups, with-
out airflow obstruction, were included for comparison.
The previous literature made use of the St George’s
Respiratory Questionnaire (SGRQ), a disease specific in-
strument widely used in research, but with limited use
in clinical practice, due to its extensiveness. This study,
in contrast, used a robust set of reliable, generic and dis-
ease specific instruments to measure health status in our
cohorts. Furthermore, the instruments included in our
study allowed the investigation of health status in
subjects who did not necessarily presented important
symptoms during daily activities.
However, the present study also has some limitations.
Subjects who dropped out during the follow up (includ-
ing deceases) were mainly included in the airflow ob-
struction (42% of drop outs) and smoking control (49%
of drop outs) groups. They had more smoking exposure,
worse lung function, functional capacity, higher symp-
toms of anxiety and worse health status. This might have
led to a selection bias of the present findings, with a
probable underestimation of the differences between
airflow obstruction group and controls. Indeed, the
subjects from the fast decline group presented worse
baseline functional outcomes than those from the slower
decline group. However, we tried to limit this selection
bias by maximally using the available data.
This study lacks the power to detect statistically
significant differences, especially in the stratification and
exploratory analyses. Nevertheless, the authors feel that
the study provides a unique insight in the trajectory of
health status in (former) smokers from the population
with and without mild to moderate airflow obstruction
and may provide data to set up fully powered studies to
investigate the impact of exacerbations in patients in the
early stages of developing clinical COPD.
Future perspectives
Despite this comprehensive design, the onset of the disab-
ling health status was, unfortunately, not captured in this
study. This would probably demand an epidemiological
study with much larger proportions in terms of sample
size and/or follow up duration, starting the inclusion at
earlier ages and before the onset of airflow obstruction.
This may not be feasible at a population level. Therefore,
tackling subjects at higher risk of rapid deterioration and
investigating the effects of early intervention in this sub-
group would be of more relevance for future studies. Our
results indicated that subjects with airflow obstruction,
acute exacerbation(s), worse diffusion capacity, hyperinfla-
tion, exercise capacity and physical activity are predis-
posed for overall fast health status deterioration.
The instruments selected to measure health status in
the current study are designed to assess general and spe-
cific disease conditions. Nevertheless, they seemed to lack
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the capability to detect subtle changes at the onset of the
disease. The development of a patient reported outcome
specifically geared to people with mild disease might be
worthwhile to detect subtle changes.
Conclusion
Subjects with mild airflow obstruction present a signifi-
cant deterioration of health status, which is generally
not much faster compared to smoking and never smok-
ing controls. Subjects with fast decline in overall health
status are older and more likely to have airflow obstruc-
tion, acute respiratory exacerbation(s), reduced physical
fitness, physical activity and impaired COPD specific
health status at baseline.
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